ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals

May 16, 2020
Alex Delaney-Gesing

Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virtual meeting.


See more ASCRS meeting coverage here